Yuteng International Group Corporation – Trademark Portfolio
Entity Type: 03
Yuteng International Group Corporation holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include WELLTY CARE. The owner is based in Irvine, CA.
17 Plumbago Road
Irvine, CA 92620
Showing of trademarks Trademarks
Trademark Classifications
Yuteng International Group Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Yuteng International Group Corporation have?
Yuteng International Group Corporation has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Yuteng International Group Corporation file in?
Yuteng International Group Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Yuteng International Group Corporation's most well-known trademarks?
Yuteng International Group Corporation's registered trademark portfolio includes well-known marks such as WELLTY CARE. These are among 1 currently registered trademark in the portfolio.
What is Yuteng International Group Corporation's trademark registration success rate?
Yuteng International Group Corporation has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.